Cargando…
Quality assurance of drugs used in clinical trials: proposal for adapting guidelines
Paul Newton and colleagues propose that clinical trial guidelines should include a requirement to assess and state the quality of the drugs and other medical products used
Autores principales: | Newton, Paul N, Schellenberg, David, Ashley, Elizabeth A, Ravinetto, Raffaella, Green, Michael D, ter Kuile, Feiko O, Tabernero, Patricia, White, Nicholas J, Guerin, Philippe J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705347/ https://www.ncbi.nlm.nih.gov/pubmed/25716700 http://dx.doi.org/10.1136/bmj.h602 |
Ejemplares similares
-
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020) -
It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North–South collaborative trials
por: Ravinetto, Raffaella, et al.
Publicado: (2016) -
Responsible dissemination of health and medical research: some guidance points
por: Ravinetto, Raffaella, et al.
Publicado: (2023) -
Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014) -
Adapting clinical guidelines in India—a pragmatic approach
por: Mehndiratta, Abha, et al.
Publicado: (2017)